Toxicity-related or tolerability-related discontinuations were more common in the triple-therapy group ( n = 10 [ 49 % ] ) than in the dual-therapy group ( n = 1 [ 04 % ] ; difference 45 % , 95 % CI -81 to -09 ; p = 0011 ) .